[Ip-health] WHO announces open sessions and open forum of first Consultative Expert Working Group on R&D Financing

Thiru Balasubramaniam thiru at keionline.org
Tue Mar 15 06:38:08 PDT 2011


Consultative expert working group on research and development:  
financing and coordination (CEWG) Invitation to attend the OPEN  
SESSIONS of the 1st Meeting of the CEWG: 5-7 April 2011: WHO Executive  
Board Room, Geneva Introduction
The CEWG (link to Members of the CEWG below) has been established in  
accordance with World Health Assembly Resolution 63.28 (link below).  
The terms of reference of the CEWG are to take forward the work of its  
predecessor, the Expert Working Group (EWG), and to deepen the  
analysis of its proposals. The EWG’s terms of reference were:

“... to examine current financing and coordination of research and  
development, as well as proposals for new and innovative sources of  
funding to stimulate research and development related to Type II and  
Type III diseases and the specific research and development needs of  
developing countries in relation to Type I 1 diseases...”

The CEWG is also asked to consider additional proposals from Member  
States 2 and from other stakeholders.

It is due to report to the World Health Assembly in 2012.

Further details on the CEWG can be found in the background paper (link  

	• Members of the CEWG
pdf, 24kb
	• Background paper
pdf, 53kb
	• World Health Assembly Resolution 63.28
pdf, 17kb
To ensure transparency in the work of the CEWG, in accordance with  
resolution WHA 63.28, three open sessions have been planned during the  
1st meeting of the CEWG.

1. Open Session on 5th April 2011, Tuesday, 9.30am to 3.30pm
The first day of the meeting will be open to all Member States 3 and  
other stakeholders from the start of the meeting at 9.30am to the  
second coffee break at 3.30pm. Other attendees than CEWG members will  
be able to participate in this session as OBSERVERS. If you are  
interested  in attending this session as an observer please click on  
"Registration form" below.

2. Open Forum on 6th April 2011, Wednesday, 9am to 6pm
All Member States 4 and other interested stakeholders are invited to a  
one day Open Forum in the Executive Board (EB) Room at the World  
Health Organization on Wednesday 6th April 2011  from 9am to 6pm.

The purpose of the Open Forum will be to enable the CEWG to understand  
better the perspective of different stakeholders on the issues before  
it and any additional submissions and proposals.

All those interested in attending this session please click on  
"Registration form" below.

As part of the Open Forum, the CEWG would also like to invite  
participants to make a presentation on a specific theme or proposal  
relevant to the CEWG’s mandate. The duration of the presentation  
should not exceed 15 minutes. If you would like to make a  
presentation, please click on the "Application form" below.

In the event of numerous indications the WHO Secretariat may recommend  
to the members of the CEWG to select several presentations to ensure a  
representative cross-section of stakeholders, and on the basis of  
maximum relevance to the CEWG’s terms of reference.

The agenda of the Open Forum will be finalised in the light of the  
offers of presentations from stakeholders. We regret that WHO cannot  
make available funding for participants, including presenters.

3. Open Briefing Session on 7th April 2011, Thursday, 5.30pm, Salle B,  
The third day of the meeting will be only for CEWG members. However,  
at the conclusion of the meeting at 5.30pm the Chair of the CEWG will  
conduct an Open Briefing Session about the outcomes of the first CEWG  
meeting and its future plan of work. If you are interested in  
attending this briefing session please register by clicking on the  
link below. A video link will be available for this briefing session  
outside Salle B.

	• Registration form
pdf, 84kb
	• Application form (presenter)
pdf, 10kb
1 Type I diseases are incident in both rich and poor countries, with  
large numbers of vulnerable populations in each. Type II diseases are  
incident in both rich and poor countries, but with a substantial  
proportion of the cases in poor countries. Type III diseases are those  
that are overwhelmingly or exclusively incident in developing countries.
2 And, where applicable, regional economic integration organizations.
3 Ibid.
4 Ibid.


Thiru Balasubramaniam
Geneva Representative
Knowledge Ecology International (KEI)
thiru at keionline.org

Tel: +41 22 791 6727
Mobile: +41 76 508 0997

More information about the Ip-health mailing list